MLANA Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesMART1; MART-1
ProductOrderM
Clone#2F3B7
Entrez GenelD2315
FormulationPurified antibody in PBS with 0.05% sodium azide.
HostMouse
IsotypeIgG1
ImmunogenPurified recombinant fragment of human MLANA (AA: 48-118) expressed in E. Coli.
MW13.2kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
WB (Western Blot)1/500 - 1/2000
Sequence
48-118
Catalog#: 30682
Inquire
Contact us to order
Images
Western Blot
Figure 1: Western blot analysis using MLANA mAb against human MLANA (AA: 48-118) recombinant protein. (Expected MW is 33.9 kDa)
Figure 1: Western blot analysis using MLANA mAb against human MLANA (AA: 48-118) recombinant protein. (Expected MW is 33.9 kDa)
Western Blot
Figure 2: Western blot analysis using MLANA mAb against HEK293 (1) and MLANA (AA: 48-118)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 2: Western blot analysis using MLANA mAb against HEK293 (1) and MLANA (AA: 48-118)-hIgGFc transfected HEK293 (2) cell lysate.
Elisa
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Product Overview
Description

MLANA (melan-A) is a protein-coding gene. Diseases associated with MLANA include meningeal melanocytoma, and juvenile xanthogranuloma. Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes

References (references)
References (references)1. Mol Med Rep. 2011 Sep-Oct;4(5):799-803.
2. J Cutan Pathol. 2011 Dec;38(12):954-60.